AGREEMENT AND PLAN OF MERGER

Agreement and Plan of Merger

You are currently viewing:

This Agreement and Plan of Merger involves

NARROWSTEP INC | ONSTREAM MEDIA CORPORATION, ONSTREAM MERGER CORP

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.

Title: AGREEMENT AND PLAN OF MERGER
Governing Law: Delaware Date: 6/3/2008
Law Firm: Arnstein Lehr;Lowenstein Sandler

AGREEMENT AND PLAN OF MERGER, Parties: narrowstep inc , onstream media corporation onstream merger corp

that

Exhibit 2.1

AGREEMENT AND PLAN OF MERGER

AMONG

ONSTREAM MEDIA CORPORATION, ONSTREAM MERGER CORP.,

NARROWSTEP INC.

AND W. AUSTIN LEWIS IV, AS STOCKHOLDER REPRESENTATIVE

----------------------------------------------------------------------------------------------------------

Dated as of May 29, 2008

----------------------------------------------------------------------------------------------------------

AGREEMENT AND PLAN OF MERGER

THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of May 29, 2008, is among Onstream Media Corporation (“Parent”), a Florida corporation, Onstream Merger Corp. (“Merger Sub”), a Delaware corporation, Narrowstep Inc. (the “Company”), a Delaware corporation, and W. Austin Lewis IV (the “Stockholder Representative”) solely for purposes of Sections 1.13, 1.14, 8.4, 8.5 and Article IX.

R E C I T A L S

A. The parties wish to effect the acquisition of the Company by Parent through a merger (the “Merger”) of Merger Sub with and into the Company on the terms and subject to the conditions set forth herein.

B. The respective Boards of Directors of Parent, Merger Sub and the Company have approved the Merger upon the terms and subject to the conditions of this Agreement.

C. The Board of Directors of the Company has (i) determined that it is fair to and in the best interests of the Company and the Company Stockholders (as defined herein) to enter into this Agreement, (ii) approved this Agreement in accordance with the General Corporation Law of the State of Delaware (the “DGCL”), and (iii) resolved to recommend the adoption of this Agreement by the Company Stockholders.

D. The respective Boards of Directors of Parent and Merger Sub have each determined that it is in the best interests of their respective companies and shareholders to enter into this Agreement and the Board of Directors of Parent has resolved to recommend the approval of the Charter Amendment (as defined herein), the Share Issuance (as defined herein) and the CVR Issuance (as defined herein) by the Parent Shareholders (as defined herein).

NOW, THEREFORE, In consideration of the mutual representations, warranties and covenants contained herein, the Parent, Merger Sub and the Company hereby agree as follows:

ARTICLE I - THE MERGER

1.1 The Merger .

(a) Upon the terms and subject to the conditions hereof, and in accordance with the DGCL, Merger Sub shall be merged with and into the Company. The Merger shall occur at the Effective Time (as defined herein). Following the Merger, the Company shall continue as the surviving corporation (sometimes referred herein as the “Surviving Corporation”) and the separate corporate existence of Merger Sub shall cease.

(b) The name of the Surviving Corporation shall be Narrowstep Inc.

1.2 Effective Time .

(a) The closing of the Merger (the “Closing”) shall take place at 10:00 a.m., Eastern time, on a date to be specified by Parent and the Company (the “Closing Date”), which shall be no later than the second business day after satisfaction or waiver of the conditions set forth in Articles V, VI and VII (other than delivery of items to be delivered at the Closing and other than satisfaction of those conditions that by their nature are to be satisfied at the Closing, it being understood that the occurrence of the Closing shall remain subject to the delivery of such items and the satisfaction or waiver of such conditions at the Closing), at the offices of Arnstein & Lehr LLP, 200 East Olas Boulevard, Suite 1700, Fort Lauderdale, Florida, unless another date, place or time is agreed to in writing by Parent and the Company.

(b) At the Closing, the parties hereto shall cause the Merger to be consummated by filing a certificate of merger (the “Certificate of Merger”) with the Secretary of State of the State of Delaware (the “Secretary of State”), in such form as required by, and executed and filed in accordance with, the relevant provisions of the DGCL (the date and time of the filing of the Certificate of Merger with the Secretary of State, or such later time as is specified in the Certificate of Merger and as is agreed to by the parties hereto, being hereinafter referred to as the “Effective Time”) and shall make all other filings or recordings required under the DGCL in connection with the Merger.

1.3 Effects of the Merger . The Merger shall have the effects set forth in this Agreement and the applicable provisions of the DGCL.

1.4 Certificate of Incorporation and By-Laws . Subject to Section 4.15(a), the Certificate of Incorporation and By-Laws of the Company, in each case as in effect immediately prior to the Effective Time shall be amended to read in their entirety as set forth on Exhibits A and B attached hereto and, as so amended, shall be the Certificate of Incorporation and By-Laws of the Surviving Corporation until thereafter changed as provided therein or by applicable law.

1.5 Directors and Officers . The directors and officers of Merger Sub immediately prior to the Effective Time shall be the directors and officers of the Surviving Corporation, in each case, until the earlier of his or her resignation or removal or otherwise ceasing to be a director or officer, as the case may be, or until his or her respective successor is duly elected or appointed and qualified. Each director of the Company immediately prior to the Effective Time shall submit his or her resignation at the Closing to be effective at the Effective Time.

1.6 Conversion of Common Stock .

(a) At the Effective Time, by virtue of the Merger and without any action on the part of Parent, Merger Sub, the Company or holders of the following securities:

(i) Subject to adjustment for fractional shares as provided in Section 1.6(a)(ii), each share of Company common stock, $0.000001 par value per share (the “Company Common Stock”), outstanding immediately prior to the Effective Time, other than (A) Dissenting Shares (as defined herein), (B) Cancelled Shares (as defined herein), (C) shares held by any Company Subsidiary (as defined in Section 2.4(a)) (“Subsidiary Held Shares”) and (D) outstanding shares issued under Company Non-accelerated Restricted Stock Awards, shall be automatically converted into and become the right to receive: (a) a number of duly authorized, validly issued, fully paid and nonassessable shares of Parent common stock, $.0001 par value per share (“Parent Common Stock”), equal to the greater of the Exchange Ratio (as defined herein) and the Minimum Exchange Ratio (as defined herein); and (b) one contingent value right (a “Contingent Value Right”) to be issued by Parent pursuant to the Contingent Value Rights Agreement (the “CVR Agreement”) in the form of Exhibit C hereto. “Exchange Ratio” means the quotient obtained by dividing (A) the sum of (x) the Annualized Company Revenue Shares (as defined herein) plus (y) the greater of (1) the amount of cash and cash equivalents held by the Company immediately prior to the Effective Time and (2) ONE MILLION FIVE HUNDRED THOUSAND (1,500,000) by (B) the total number of shares of Company Common Stock outstanding immediately prior to the Effective Time (including any outstanding shares issued under Company Restricted Stock Awards (as defined herein) and excluding Cancelled Shares and Subsidiary Held Shares). “Minimum Exchange Ratio” means the quotient obtained by dividing (X) TEN MILLION FIVE HUNDRED THOUSAND (10,500,000) by (Y) the total number of shares of Company Common Stock outstanding immediately prior to the Effective Time (including any outstanding shares issued under Company Restricted Stock Awards and excluding Cancelled Shares and Subsidiary Held Shares). The (1) shares of Parent Common Stock payable pursuant to this Section 1.6(a)(i), as adjusted for fractional shares pursuant to Section 1.6(a)(ii); (2) shares of Parent Common Stock payable pursuant to Section 1.6(a)(iv), as adjusted for fractional shares pursuant to Section 1.6(a)(ii); (3) shares of Parent Common Stock payable pursuant to Section 1.7(b)(i) and (4) any additional shares of Parent Common Stock issued in connection with the Contingent Value Rights, are referred to collectively as the “Merger Consideration.” The Merger Consideration shall not exceed twenty million (20,000,000) shares of Parent Common Stock.

(ii) No fractional shares of Parent Common Stock shall be issued pursuant to this Agreement. In lieu of fractional shares, each stockholder who would otherwise have been entitled to a fraction of a share of Parent Common Stock hereunder (after aggregating all fractional shares to be received by such stockholder), shall receive an amount equal to the Parent Common Stock Price (as defined herein) multiplied by the fraction of a share of Parent Common Stock to which such holder would otherwise be entitled. “Parent Common Stock Price” means the average of the last reported sale prices of the Parent Common Stock for the fifteen consecutive trading days ending on the fifth trading day prior to the Effective Time on the primary exchange on which the Parent Common Stock is traded.

(iii) Notwithstanding anything in the foregoing to the contrary, if between the date of this Agreement and the Effective Time there is a change in the number or class of issued and outstanding shares of Parent Common Stock or Company Common Stock as the result of reclassification, subdivision, recapitalization, stock split (including reverse stock split), stock dividend, combination or exchange of shares, the Merger Consideration shall be correspondingly adjusted to reflect such event.

(iv) Subject to adjustment for fractional shares as provided in Section 1.6(a)(ii), each share of Series A preferred stock, par value $0.000001 per share, of the Company (the “Company Series A Preferred Stock”), outstanding immediately prior to the Effective Time, shall be automatically converted into and become the right to receive: (a) a number of duly authorized, validly issued, fully paid and nonassessable shares of Parent Common Stock equal to the Preferred Stock Exchange Ratio (as defined herein). "Preferred Stock Exchange Ratio" means the quotient obtained by dividing SIX HUNDRED THOUSAND (600,000) by the number of shares of Company Series A Preferred Stock outstanding immediately prior to the Effective Time.

(b) Each share of Company Common Stock that is owned, directly or indirectly, by Parent or Merger Sub immediately prior to the Effective Time, if any, or that is held in treasury by the Company immediately prior to the Effective Time (collectively, the “Cancelled Shares”) shall, by virtue of the Merger and without any action on the part of the holder thereof, be cancelled and shall cease to exist, and no consideration shall be delivered in exchange for such cancellation.

(c) Each issued and outstanding share of the capital stock of Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into and become one fully paid and nonassessable share of common stock, par value $0.01 per share, of the Surviving Corporation.

(d) “Annualized Company Revenue Shares” means a number of shares of Parent Common Stock equal to the product of (A) two (2) multiplied by (B) the amount of the Annualized Company Revenue.

(e) “Annualized Company Revenue” means an amount equal to four multiplied by the Quarterly Billings (as defined herein). For purposes of this Agreement, “Quarterly Billings” means an amount equal to (A) the product of (x) 0.92 and (y) the Company’s consolidated recognized revenue for the fiscal quarter ended May 31, 2008 (such period, the “Prior Full Period”), as determined in accordance with generally accepted accounting principles, applied on a basis consistent with the Company’s financial statements, plus (B) the product of (i) three (3) multiplied by (ii) the aggregate of the per month recurring fees and charges (whether billed or unbilled) payable to the Company for all Eligible Contracts (as defined below) to which the Company or any subsidiary of the Company is a party (whether entered into before, during or after the Prior Full Period) for the initial month of each such contract during which a monthly fee is charged, but in the case of this clause (B) only to the extent such amounts have not been included in the amount calculated pursuant to the immediately preceding clause (A) less (C) (i) to the extent included in the immediately preceding clause (A), any non-recurring fees from a single customer that exceed in the aggregate for such customer $212,000; and (ii) to the extent included in the immediately preceding clause (A), revenues from customers who have terminated contracts or agreements (whether terminated before, during or after the Prior Full Period) on or prior to the Effective Time. “Eligible Contracts” means those contracts for which (i) the Company or any subsidiary of the Company has received payment in full of “set-up” fees payable to the Company or any subsidiary of the Company thereunder; and (ii) the Company or any subsidiary of the Company has verified the credit history of the other party to the contract by performing a credit check consistent with the Company’s past practices.

(f) As of the Effective Time, the Surviving Corporation shall assume the obligations of the Company under the warrant agreements set forth on the Company Disclosure Schedule in respect of the Company Warrants (as defined herein). The holders of the Company Warrants shall continue to have, and be subject to, the same terms and conditions set forth in such Company Warrants (including, without limitation, any provision contained therein relating to the repurchase or redemption thereof), except that each such Company Warrant shall (A) (1) in the case of a Company Warrant that is not a Company 2007 Warrant (as defined herein), be exercisable for (i) that number of shares of Parent Common Stock equal to the product of the number of shares of Company Common Stock covered by the Company Warrant immediately prior to the Effective Time multiplied by the greater of the Exchange Ratio and the Minimum Exchange Ratio, and (ii) the per share exercise price for the shares of Parent Common Stock issuable upon the exercise of such assumed Company Warrant shall be equal to the quotient obtained by dividing the exercise price per share of Company Common Stock specified in such Company Warrant in effect immediately prior to the Effective Time by the greater of the Exchange Ratio and the Minimum Exchange Ratio, rounding the resulting exercise price down the nearest whole cent; and (2) in the case of a Company 2007 Warrant, be exercisable for that number of shares of Parent Common Stock, and at a per share exercise price, as set forth in the terms of the Company 2007 Warrants; and (B) in the case of all Company Warrants, upon such exercise described in the immediately preceding clause (A), without any further payment required on the part of the holders, receive such number of Contingent Value Rights that such holders would have been entitled to receive upon conversion of the resulting shares of Company Common Stock in connection with the Merger if such Company Warrants had been exercised by such holders immediately prior to the Effective Time. Notwithstanding anything to the contrary, nothing contained herein shall require Parent to issue fractional shares of Parent Common Stock upon the exercise of any Company Warrant. At the Effective Time, Parent shall reserve for issuance the number of shares of Parent Common Stock that will become issuable upon the exercise of such Company Warrants pursuant to this Section 1.6(f) assuming the full exercise of all Company Warrants. Notwithstanding anything in the foregoing to the contrary, in the event a holder exercises a Company Warrant (other than a Company 2007 Warrant) prior to the time of a final determination pursuant to Section 1.13 that the Exchange Ratio is greater than the Minimum Exchange Ratio, then as soon as practicable following such determination Parent shall issue and deliver to such holder a certificate representing that number of whole shares of Parent Common Stock into which the Company Warrants so exercised shall have been converted pursuant to the provisions of this Agreement applying the Exchange Ratio (as opposed to the Minimum Exchange Ratio) under this Section 1.6(f) less any shares of Parent Common Stock issued and delivered to such holder respect of such prior exercise. Holders of Company Warrants who exercise such warrants subsequent to the Final Exercise Date (as defined in the CVR Agreement) shall not be entitled to Contingent Value Rights. For purposes of this Agreement, "Company 2007 Warrants" means those Company Warrants issued pursuant to that certain Purchase Agreement, dated as of August 8, 2007, as amended, by and among the Company and the purchasers named therein.

(g) Notwithstanding anything in this Agreement to the contrary, any shares of Company Common Stock which are issued and outstanding immediately prior to the Effective Time and are held by a person (a “ Dissenting Stockholder ”) who has not voted in favor of or consented to the adoption of this Agreement and has complied with all the provisions of Section 262 of the DGCL concerning the right of holders of shares of Company Common Stock to require appraisal of their Shares (“ Dissenting Shares ”) shall not be converted into the right to receive the applicable Merger Consideration, and the holders of such Dissenting Shares shall be entitled to receive payment of the fair value of such Dissenting Shares in accordance with the provisions of Section 262 of the DGCL; provided, however, that if such Dissenting Stockholder withdraws its demand for appraisal or fails to perfect or otherwise loses its right of appraisal, in any case pursuant to Section 262 of the DGCL, its shares of Company Common Stock shall be deemed to be converted as of the Effective Time into the right to receive the applicable Merger Consideration for each such share of Company Common Stock in accordance with the provisions of this Agreement. At the Effective Time, any holder of Dissenting Shares shall cease to have any rights with respect thereto, except the rights set forth in Section 262 of the DGCL and as provided in the previous sentence. The Company shall give Parent prompt notice of any demands for appraisal of shares of Company Common Stock received by the Company, withdrawals of such demands and any other instruments served pursuant to Section 262 of the DGCL and shall give Parent the opportunity to participate in all negotiations and proceedings with respect thereto.

1.7 Company Options, Restricted Stock and Restricted Stock Units .

(a) For a period of at least fifteen (15) days prior to the Effective Time, the Company shall provide each holder of an option (“ Company Option ”) granted by the Company under the Narrowstep Inc. 2004 Stock Plan (the “ Company Stock Plan ”) or otherwise with the opportunity to exercise each such Company Option, regardless of whether such Company Option is otherwise vested or exercisable. To the extent that any such Company Option is not exercised prior to the Effective Time, such Company Option shall be canceled and be of no further force and effect. If any Company Options are exercised prior to the Effective Time, any shares of Company Stock issued as a result thereof will be included in the total number of shares of Company Common Stock outstanding per Section 1.6(a)(i).

(b) At the Effective Time, each outstanding share of Company Common Stock that, immediately prior to the Effective Time, is then the subject of a restricted stock award (excluding any Company Accelerated Restricted Stock (as defined herein)) granted under the Company Stock Plan or otherwise (such awards, "Company Non-accelerated Restricted Stock Awards") shall automatically and without any action on the part of the holder thereof, be converted into (i) a number of shares of restricted Parent Common Stock (“ Parent Restricted Stock ”) equal to the greater of the Exchange Ratio and the Minimum Exchange Ratio on the same terms and conditions (including applicable vesting rights) as applicable to such Company Non-accelerated Restricted Stock Awards set forth in the Company Stock Plan and the award agreements pursuant to which such Company Non-accelerated Restricted Stock Awards were issued as in effect immediately prior to the Effective Time; (ii) cash in lieu of fractional shares pursuant to Section 1.6(a)(ii); and (iii) one (1) Contingent Value Right that is unvested but subject to future vesting in accordance with the same vesting schedule and other requirements (and cancellation conditions) applicable to such Company Non-accelerated Restricted Stock Award; provided, however, that until such time as a final determination of the Exchange Ratio is made pursuant to Section 1.13, the Parent Restricted Stock issuable pursuant to the immediately preceding sentence shall be issued in such amount as if the Minimum Exchange Ratio was used in calculating the conversion of each Company Non-accelerated Restricted Stock Award pursuant hereto. Notwithstanding anything in the foregoing to the contrary, in the event that it is finally determined pursuant to Section 1.13 that the Exchange Ratio is greater than the Minimum Exchange Ratio, each share of Parent Restricted Stock issued or to be issued pursuant to the immediately preceding sentence, shall, as of the date such final determination, automatically and without any action on the part of the holder thereof, be converted into such number of shares of Parent Restricted Stock as if the Exchange Ratio was applicable at the Effective Time, on the same terms and conditions of such Parent Restricted Stock issued pursuant to the first sentence of this Section 1.7(b). Parent shall file a registration statement on Form S-8 as of or prior to the Effective Time with respect to shares of Parent Restricted Stock and shall use commercially reasonable efforts to maintain the effectiveness of such registration statement (and maintain the current status of the prospectus or prospectuses contained therein) for so long as such shares of Parent Restricted Stock remain unvested.

(c) Immediately prior to the Effective Time, each share of Company Common Stock outstanding on the date of this Agreement that is (i) subject to a restricted stock award; (ii) subject to a written agreement or provision that provides for the acceleration of vesting in the event of a change in control of the Company that results in a termination of employment; and (iii) held by a person who has been terminated from service by the Company on or after the date of this Agreement and prior to the Effective Time ("Company Accelerated Restricted Stock") shall become fully vested without any further action required on the part of the holder thereof or the Company. The shares of Company Accelerated Restricted Stock that vest pursuant to this Section 1.7(c) shall be treated as outstanding shares of Company Common Stock immediately prior to the Effective Time.

(d) Immediately prior to the Effective Time, each restricted stock unit that is then the subject of a restricted stock unit award evidencing the right to receive shares of Company Common Stock granted under the Company Stock Plan or otherwise (each a “ Company RSU ”) shall become fully vested and the Company shall issue the holder thereof a share of Company Common Stock for each such Company RSU, whereupon the respective Company RSU shall thereupon be canceled and of be of no further force and effect. The shares of Company Common Stock issued in respect of Company RSUs will be treated as outstanding immediately prior to the Effective Time.

(e) Immediately prior to the Effective Time, the Company shall issue the holder of each Company RSU that had previously vested, but with respect to which the delivery of shares of Company Common Stock was delayed or deferred for any reason, a share of Company Common Stock for each such Company RSU, whereupon the respective Company RSU shall thereupon be canceled and be of no further force and effect. The shares of Company Common Stock issued in respect of Company RSUs will be treated as outstanding immediately prior to the Effective Time.

(f) Each share of Company Common Stock issued pursuant to Section 1.7(a), (c), (d) or (e) above shall by virtue of the Merger and without any action on the part of the holder thereof be converted into the right to receive the Merger Consideration in respect of each such share of Company Common Stock in accordance with Section 1.6(a).

1.8 Exchange of Certificates . Promptly after the Effective Time, Parent shall authorize a bank or trust company to act as exchange agent hereunder, which bank or trust company shall be reasonably acceptable to the Company (the “Exchange Agent”). As soon as practicable after the Effective Time, Parent shall cause the Exchange Agent to mail, to all former holders of record of (i) an outstanding certificate or certificates which immediately prior to the Effective Time represented shares Company Common Stock or Company Series A Preferred Stock that were converted into the right to receive Merger Consideration pursuant to this Agreement (the “Certificates”) or (ii) shares represented by book-entry which immediately prior to the Effective Time represented shares of Company Common Stock that were converted into the right to receive Merger Consideration pursuant to this Agreement (“Book-Entry Shares”), (A) instructions for surrendering their Certificates, or in the case of Book-Entry Shares, for surrendering such shares, in exchange for a certificate representing shares of Parent Common Stock and cash in lieu of fractional shares and, in the case of former holders of record of Company Common Stock, a certificate representing a Contingent Value Right, and (B) a letter of transmittal (the “Letter of Transmittal”), which shall specify that delivery shall be effected, and risk of loss of, and title to, the Certificates shall pass, only upon delivery of the Certificates to the Exchange Agent, or in the case of Book-Entry Shares, upon adherence to the procedures set forth in the Letter of Transmittal. Upon surrender of Certificates or Book-Entry Shares, for cancellation to the Exchange Agent, together with Letter of Transmittal and such other customary documents reasonably requested by Parent and in accordance with the instructions thereon, each holder of such Certificates and Book-Entry Shares shall be entitled to receive in exchange therefor (a) a certificate representing that number of whole shares of Parent Common Stock into which the shares of Company Common Stock or Company Series A Preferred Stock theretofore represented by the Certificates or Book-Entry Shares so surrendered shall have been converted pursuant to the provisions of this Agreement applying the Minimum Exchange Ratio under Section 1.6(a)(i) and with respect to Company Series A Preferred Stock the Preferred Stock Exchange Ratio, (b) any cash in lieu of fractional shares pursuant to Section 1.6(a)(ii) hereof, (c) a certificate representing that number of Contingent Value Rights, if any, to which such holder is entitled under this Agreement, (d) a check in the amount of any cash due pursuant to Section 1.12 hereof, and (e) in the case of Company Common Stock only the right to receive a certificate representing that number of whole shares of Parent Common Stock into which the shares of Company Common Stock theretofore represented by the Certificates or Book-Entry Shares so surrendered shall have been converted pursuant to the provisions of this Agreement applying the Exchange Ratio (as opposed to the Minimum Exchange Ratio) under Section 1.6(a)(i) less any shares of Parent Common Stock issued and delivered to former holders of Company Common Stock in accordance with clause (a) of this sentence, but in the case of this clause (e) only to the extent that it is determined pursuant to Section 1.13 that the Exchange Ratio is greater than the Minimum Exchange Ratio. No interest shall be paid or shall accrue on any such amounts. Until surrendered in accordance with the provisions of this Section 1.8, each Certificate and each Book-Entry Share shall represent for all purposes only the right to receive Merger Consideration together with cash in lieu of any fractional shares to which such holder is entitled pursuant to Section 1.6(a)(ii) hereof and, if applicable, amounts under Section 1.12 hereof. Shares of Parent Common Stock into which shares of Company Common Stock and shares of Company Series A Preferred Stock shall be converted in the Merger at the Effective Time shall be deemed to have been issued at the Effective Time. If any certificates representing shares of Parent Common Stock are to be issued in a name other than that in which the Certificate surrendered is registered, it shall be a condition of such exchange that the person requesting such exchange shall deliver to the Exchange Agent all documents necessary to evidence and effect such transfer and shall pay to the Exchange Agent any transfer or other taxes required by reason of the issuance of a certificate representing shares of Parent Common Stock in a name other than that of the registered holder of the Certificate surrendered, or establish to the satisfaction of the Exchange Agent that such tax has been paid or is not applicable. Beginning on the date which is twelve (12) months following the Effective Time, Parent shall act as the Exchange Agent and thereafter any holder of an unsurrendered Certificate or Book-Entry Share shall look solely to Parent and the Surviving Corporation for any amounts to which such holder may be due, subject to applicable law. The Surviving Corporation shall pay all charges and expenses, including those of the Exchange Agent, in connection with the exchange of the shares of Company Common Stock and Company Series A Preferred Stock for the Merger Consideration.

1.9 No Liability . None of Parent, the Surviving Corporation or the Exchange Agent shall be liable to any person in respect of any shares of Parent Company Stock (or dividends or distributions with respect thereto) or cash payments delivered to a public official pursuant to any applicable escheat, abandoned property or similar law.

1.10 Lost Certificates . If any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the person claiming such Certificate to be lost, stolen or destroyed and, if required by Exchange Agent, the posting by such person of a bond in such reasonable amount as Exchange Agent may direct as indemnity against any claim that may be made against it with respect to such Certificate, the Exchange Agent shall deliver in exchange for such lost, stolen or destroyed Certificate, applicable certificates representing shares of Parent Common Stock and any cash in lieu of fractional shares pursuant to Section 1.6(a)(ii) and, if applicable, certificates representing Contingent Value Rights and any amounts due pursuant to Section 1.12 hereof, deliverable in respect thereof pursuant to this Agreement.

1.11 Withholding Rights . Parent shall be entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement to any holder of shares of Company Common Stock or Company Series A Preferred Stock such amounts as it is required to deduct and withhold with respect to the making of such payment under the Internal Revenue Code of 1986, as amended (the “Code”), or any provision of state, local or foreign tax law. To the extent that amounts are so withheld and paid over to the appropriate taxing authority by Parent, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the holder of the shares of Company Common Stock or the Company Series A Preferred Stock, as applicable, in respect of which such deduction and withholding was made.

1.12 Distributions with Respect to Unexchanged Shares . No dividend or other distribution declared with respect to Parent Common Stock with a record date after the Effective Time shall be paid to holders of unsurrendered Certificates or Book-Entry Shares until such holders surrender such Certificates or Book-Entry Shares for exchange as provided for herein. Upon the surrender of such Certificates and Book-Entry Shares in accordance with Section 1.8, there shall be paid to such holders, promptly after such surrender in addition to the applicable Merger Consideration as provided in Section 1.6 (including any cash paid or other distributions pursuant to Section 1.6(a)(ii)), (i) the amount of dividends or other distributions, without interest, declared with a record date after the Effective Time and not paid because of the failure to surrender such Certificates or Book-Entry Shares for exchange, and (ii) at the appropriate payment date, the amount of dividends or other distributions, without interest, declared with a record date after the Effective Time but prior to such surrender and with a payment date subsequent to such surrender payable with respect to such whole shares of Parent Common Stock.

1.13 Additional Shares .

(a) Not later than five business days after the Closing Date, Parent shall deliver to the Stockholder Representative, a certificate setting forth the calculation of the Exchange Ratio (“ Parent’s Report ”).

(b) If within thirty (30) days upon delivery of Parent’s Report, Stockholder Representative has not given written notice of its objection to such report (which notice shall state in reasonable detail the basis of Stockholder Representative’s response or objection), then such Parent’s Report shall be binding. If Stockholder Representative gives Parent a written objection and if the parties fail to resolve the issues outstanding with respect to such report within a period of thirty (30) days after notification of rejection, the parties shall submit the issues remaining in dispute to an independent public accounting firm (the “ Independent Accountant ”) acceptable to the parties for resolution. The parties agree to execute such engagement or similar letter as reasonably requested by the Independent Accountant. If issues are submitted to the Independent Accountant for resolution, the parties shall or cause to be furnished to the Independent Accountant such work papers and other documents and information related to those disputed issues as the Independent Accountant may request and are available to that party or its representatives before the opportunity to present to the Independent Accountant any material related to the disputed issues and discuss the issues with the Independent Accountant. Parent and the Stockholder Representative shall use their commercially reasonable efforts to cause the Independent Accountant to make a determination within thirty days of accepting its selection.

(c) The decision of the Independent Accountant shall be final, binding and conclusive resolution of the parties’ dispute, shall be non-appealable and shall not be subject to further review.

(d) Parent will bear one hundred percent (100%) of the fees and costs of the Independent Accountant for such determination; provided, however, that in the event that the Independent Accountant determines pursuant to Section 1.13(b) that Parent’s Report, as submitted pursuant to Section 1.13(a), is correct, then the fees and costs of the Independent Accountant (the “Accountant Fees”) shall be paid by Parent to the Independent Accountant and to the extent so paid shall be set off against the number of shares of Parent Common Stock issuable pursuant to Section 1.13(g), on a pro rata basis and if no additional shares are issued, pursuant to Section 1.13(g), Parent shall be able to offset such amount against any CVR Shares (as defined in the CVR Agreement) that may be issued pursuant to the CVR Agreement, in each case in accordance with the following sentences. The aggregate number of shares issuable pursuant to Section 1.13(g) shall be reduced by an amount equal to the quotient obtained by dividing the Accountant’s Fees by the average of the last reported sales prices of Parent Common Stock on the primary exchange where it is traded for the last fifteen trading days immediately preceding the date on which the right to set off arises pursuant to the immediately preceding sentence. To the extent the quotient calculated pursuant to the immediately preceding sentence is less than the amount of the Accountant’s Fees payable by the former stockholders of the Company (such deficient amount, the "Accountant’s Fees Deficiency”), the number of CVR Shares issuable pursuant to the CVR Agreement share be reduced in the aggregate by an amount equal to the quotient obtained by dividing the Accountant’s Fees Deficiency by the average of the last reported sales prices of Parent Common Stock on the primary exchange where it is traded for the last fifteen trading days immediately preceding the date on which the CVR Year One Exchange Ratio and the CVR Year Two Exchange Ratio, as applicable, are finally determined.

(e) Upon delivery of Parent’s Report, Parent will provide the Stockholder Representative and its accountants and advisors access to (i) Parent’s Chief Financial Officer for questions, and (ii) the books and records of the Surviving Corporation (including any work papers used to prepare Parent’s Report) and such other information requested by such persons, in each case to the extent reasonably necessary related to the Stockholder Representative’s evaluation of a Parent’s Report and the calculations thereof.

(f) As promptly as practicable after Parent’s Report becomes final pursuant to this Section 1.13, Parent shall cause to be mailed a notice to each former holder of record of Company Common Stock who surrenders Certificates or Book-Entry Shares pursuant to Section 1.8 specifying the amount of the Exchange Ratio and the number of any additional shares of Parent Common Stock, if any, issuable to such holders pursuant to this Agreement.

(g) In the event that the Exchange Ratio is greater than the Minimum Exchange Ratio, as finally determined pursuant to this Section 1.13, then Parent and Exchange Agent shall cause to be issued and delivered, within thirty days of such final determination, to each former holder of record of Company Common Stock that surrenders Certificates or Book-Entry Shares pursuant to Section 1.8, (i) a certificate representing that number of whole shares of Parent Common Stock into which the shares of Company Common Stock theretofore represented by the Certificates or Book-Entry Shares surrendered pursuant to Section 1.8 shall have been converted pursuant to the provisions of this Agreement applying the Exchange Ratio (as opposed to the Minimum Exchange Ratio) under Section 1.6(a)(i) less any shares of Parent Common Stock issued and delivered to such holder in accordance with clause (a) of the third sentence of Section 1.8 hereof; (ii) any cash in lieu of fractional shares pursuant to Section 1.6(a)(ii) hereof; and (iii) a check in the amount of any cash due pursuant to Section 1.12 hereof.

1.14 Appointment of Stockholder Representative .

(a) The (i) adoption of the Merger Agreement by the former holders of record of Company Common Stock, and (ii) any exercise of the Company Warrants by the holders thereof (such holders, together with the former stockholders of record of the Company, the “Former Company Stockholders”), shall constitute by each such person, respectively, the authorization, designation and appointment of the Stockholder Representative, in each case to act as the sole and exclusive agent, attorney-in-fact and representative of each of the Former Company Stockholders by the consent of the Former Company Stockholders and as such is hereby authorized and directed to (a) take any and all actions (including without limitation executing and delivering any documents, incurring any costs and expenses for the account of the Former Company Stockholders and making any and all determinations required by this Agreement) which may be required in carrying out his duties under this Agreement, (b) give notices and communications on behalf of the stockholder as set forth in this Agreement, (c) exercise such other rights, power and authority as are authorized, delegated and granted to the Stockholder Representative under this Agreement and hereby, and (d) exercise such rights, power and authority as are incidental to the foregoing, and any decision or determination made by the Stockholder Representative consistent therewith shall be absolutely and irrevocably binding on each Former Company Stockholder as if such stockholder personally had taken such action, exercised such rights, power or authority or made such decision or determination in such Former Company Stockholder’s individual capacity.

(b) The Stockholder Representative shall not be liable, in any manner or to any extent, for any mistake or fact or error of judgment or for any acts or omissions by it of any kind, except to the extent that such action or inaction shall have been held by a court of competent jurisdiction to constitute willful misconduct or gross negligence. The Former Company Stockholders shall jointly and severally indemnify the Stockholder Representative and hold it harmless against any and all liabilities incurred by it, except for liabilities incurred by the Stockholder Representative resulting from its own willful misconduct or gross negligence, provided, however, that any indemnification obligations of the Former Company Stockholders shall be satisfied solely out of the shares of Parent Common Stock issuable pursuant to Section 1.13 of this Agreement and the CVR Shares issuable under the CVR Agreement, in each case only to the extent such shares of Parent Common Stock and CVR Shares were not issued prior to the time such indemnification obligation arises. The Stockholder Representative shall be entitled to receive a number of shares of Parent Common Stock and CVR Shares equal to the quotient obtained by dividing the amount of the indemnification obligation referenced in the immediately preceding sentence by the average of the last reported sales prices of Parent Common Stock on the primary exchange where it is traded for the last fifteen trading days immediately preceding the date of issuance of shares of Parent Common Stock pursuant to Section 1.13 hereof, and, in the case of CVR Shares, the date of issuance of such shares pursuant to the CVR Agreement.

(c) A decision, act, consent or instruction of the Stockholder Representative shall constitute a decision of all Former Company Stockholders and shall be final, binding and conclusive upon each such Holder, and Parent may rely upon any decision, act, consent or instruction of the Stockholder Representative as being the decision, act, consent or instruction of each and every such Former Company Stockholder.

ARTICLE II - REPRESENTATIONS AND WARRANTIES OF COMPANY

Except (i) as set forth on Schedule C hereto delivered by the Company to Parent and Merger Sub on the date hereof (the “ Company Disclosure Schedule ”), the section numbers of which are numbered to correspond to the section numbers of this Agreement to which they refer, it being agreed that disclosure of any item in any section of the Company Disclosure Schedule shall also be deemed disclosure with respect to any other section of this Agreement to which the relevance of such item is reasonably apparent, or (ii) as a result of any actions taken or not taken by the Company or any Company Subsidiary (as defined herein) in accordance with or pursuant to the Plan (as defined herein), the Company hereby makes the following representations and warranties to Parent and Merger Sub:

2.1 Organization and Qualification .

(a) Each of the Company and each Company Subsidiary (as defined in Section 2.4(a)) is a corporation or other legal entity duly organized, validly existing and in good standing (with respect to jurisdictions that recognize the concept of good standing) under the laws of its jurisdiction of organization and has corporate or similar power and authority to own, lease and operate its assets and to carry on its business as now being conducted, except where any such failure to have such power or authority would not, individually or in the aggregate, have a Company Material Adverse Effect (as defined herein). Each of the Company and each Company Subsidiary is qualified or otherwise authorized to transact business as a foreign corporation or other organization in all jurisdictions in which such qualification or authorization is required by law, except for jurisdictions in which the failure to be so qualified or authorized would not reasonably be expected to have a Company Material Adverse Effect. “ Company Material Adverse Effect ” means any fact, circumstance, event, change, effect or occurrence that, individually or in the aggregate with all other facts, circumstances, events, changes, effects, or occurrences, has or would be reasonably expected to have a material adverse effect on or with respect to the business, results of operation or financial condition of the Company and the Company Subsidiaries taken as a whole, provided, however, that a Company Material Adverse Effect shall not include facts, circumstances, events, changes, effects or occurrences (i) generally affecting the economy or the financial, debt, credit or securities markets in the United States, including as a result of changes in geopolitical conditions, (ii) generally affecting any of the industries in which the Company or the Company Subsidiaries operate, (iii) resulting from the announcement of this Agreement, (iv) resulting from changes in any applicable laws or regulations or applicable accounting regulations or principles or interpretations thereof, (v) resulting from any actions taken pursuant to or in accordance with the terms of this Agreement or the Plan (as defined herein) (including without limitation, Section 4.1(c)) or at the request of, or with the approval by, Parent (collectively, “ Permitted Actions ”), (vi) resulting from any outbreak or escalation of hostilities or war or any act of terrorism, (vii) resulting from any failure by the Company to meet its internal or published projections, budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations, in and of itself (it being understood that the facts or occurrences giving rise or contributing to such failure that are not otherwise excluded from the definition of a “Company Material Adverse Effect” may be taken into account in determining whether there has been a Company Material Adverse Effect), or (viii) resulting from a decline in the price of the Company Common Stock on the Bulletin Board Market (it being understood that the facts or occurrences giving rise or contributing to such decline that are not otherwise excluded from the definition of a “Company Material Adverse Effect” may be taken into account in determining whether there has been a Company Material Adverse Effect).

(b) The Company has previously provided or made available to Parent true, correct and complete copies of the charter and bylaws or other organizational documents of the Company and each Company Subsidiary as in effect on the date of this Agreement, and none of Company or any Company Subsidiary is in violation of any provisions of such documents, except as would not reasonably be expected to have a Company Material Adverse Effect.

2.2 Authority to Execute and Perform Agreements . The Company has the corporate power and authority to enter into, execute and deliver this Agreement, and, subject to receipt of the Company Requisite Vote (as defined herein), to perform its obligations hereunder and to consummate the transactions contemplated hereby. The Board of Directors of the Company has duly authorized the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby. No other corporate proceeding on the part of the Company is necessary to consummate the transactions contemplated hereby other than the adoption of this Agreement by the requisite holders of Company Common Stock and, depending on the date and terms of issuance of the Company Series A Preferred Stock, the requisite holders of Company Series A Preferred Stock (and the filing with the Secretary of State of the State of Delaware of the Certificate of Merger as required by the DGCL). This Agreement has been duly executed and delivered by the Company and, assuming the due authorization, execution and delivery by Parent and Merger Sub, constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other similar Laws relating to creditors’ rights generally and to general principles of equity. The only vote of Company stockholders required to adopt this Agreement is (i) the affirmative vote of a majority of the outstanding shares of Company Common Stock to adopt this Agreement and (ii) depending on the date and terms of issuance of the Company Series A Preferred Stock, the affirmative vote of a majority of the outstanding shares of Company Series A Preferred Stock to adopt this Agreement ((i) and (ii) collectively, the “Company Requisite Vote”).

2.3 Capitalization and Title to Shares .

(a) The authorized capital stock of the Company consists of (i) 450,000,000 shares of Company Common Stock, and (ii) 50,000 shares of undesignated preferred stock, par value $0.000001 per share (“ Company Preferred Stock ”). As of February 29, 2008, (A) 137,561,227 shares of Company Common Stock were issued and outstanding (which amount includes outstanding shares issued under Company Restricted Share Awards), (B) no shares of Company Preferred Stock were issued an outstanding and (C) no shares are issued and held in the treasury of the Company. All of the issued and outstanding shares of Company’s Common Stock are duly authorized, validly issued, fully paid, nonassessable and free of preemptive rights. Prior to the Effective Time, up to 50,000 shares of Company Series A Preferred Stock will be issued and outstanding and such shares will be duly authorized, validly issued, fully paid and nonassessable.

(b) The Company has reserved 27,000,000 shares of Company Common Stock for issuance pursuant to all Company Options. As of February 29, 2008, Company Options to purchase 8,233,635 shares of Company Common Stock were outstanding. Section 2.3(b) of the Company Disclosure Schedule sets forth with respect to each Company Option outstanding as of February 29, 2008, (i) the number of shares of Company Common Stock issuable therefor and (ii) the purchase price payable therefor upon the exercise of each such Company Option. True and complete copies of all instruments (or the forms of such instruments) referred to in this Section 2.3 (b) have been furnished previously or otherwise made available to Parent.

(c) The Company has reserved 27,000,000 shares of Company Common Stock for issuance pursuant to all shares of Company Common Stock subject to restricted stock awards granted under the Company Stock Plan or otherwise (including (i) any “Bonus Restricted Shares” issued pursuant to that certain Employment Agreement, dated June 8, 2007, by and between the Company and David C. McCourt; (ii) any Company Non-accelerated Restricted Stock Awards; and (iii) any Company Accelerated Restricted Stock) (collectively, "Company Restricted Stock Awards"). As of February 29, 2008, 17,108,500 shares of Company Common Stock were subject to Company Restricted Stock Awards. Section 2.3(c) of the Company Disclosure Schedule sets forth each Restricted Stock Award outstanding as of February 29, 2008, and the number of shares of Company Common Stock subject to the award. The Company has reserved 2,500,000 shares of Company Common Stock for issuance pursuant to all Company RSUs. As of February 29, 2008, 1,250,000 shares of Company Common Stock were subject to Company RSUs. Section 2.3(c) of the Company Disclosure Schedule sets forth each Company RSU outstanding as of February 29, 2008, and the number of shares of Company Common Stock subject to the award. True and complete copies of all instruments (or the forms of such instruments) referred to in this Section 2.3 (c) have been furnished previously or otherwise made available to Parent.

(d) As of February 29, 2008, warrants to acquire 39,433,273 shares of Company Common Stock were issued and outstanding (“ Company Warrants ”) , which includes 22,726,400 Company 2007 Warrants . Section 2.3(d) of the Company Disclosure Schedule includes a true and complete list of all outstanding Company Warrants.

(e) Except for (i) shares indicated as issued and outstanding on February 29, 2008 in Section 2.3(a) and (ii) shares issued after February 29, 2008, upon (A) the exercise of outstanding Company Options listed in Section 2.3(b) of the Company Disclosure Schedule, (B) the vesting of outstanding Company Restricted Stock Awards and Company RSUs listed in Section 2.3(c) of the Company Disclosure Schedule, or (C) the exercise of outstanding Company Warrants listed in Section 2.3(d) of the Company Disclosure Schedule, there are not as of the date hereof, and at the Effective Time, except as set forth in Section 2.3(e) of the Company Disclosure Schedule, there will not be, any shares of Company Common Stock issued and outstanding.

(f) Other than Company Options listed in Section 2.3(b) of the Company Disclosure Schedule, the Company Restricted Stock Awards listed in Section 2.3(c) of the Company Disclosure Schedule, the Company RSUs listed in Section 2.3(c) of the Company Disclosure Schedule, and the Company Warrants listed in Section 2.3(d) of the Company Disclosure Schedule, and except as set forth in Section 2.3(f) of the Company Disclosure Schedule, there are not, as of the date of this Agreement, authorized or outstanding any subscriptions, options, conversion or exchange rights, warrants, repurchase or redemption agreements, or other agreements or commitments of any nature whatsoever obligating the Company to issue, transfer, deliver or sell, or cause to be issued, transferred, delivered, sold, repurchased or redeemed, additional shares of the capital stock or other securities of the Company or obligating the Company to grant, extend or enter into any such agreement. Except as set forth in Section 2.3(f) of the Company Disclosure Schedule, to the knowledge of the Company, there are no stockholder agreements, voting trusts, proxies or other agreements, instruments or understandings with respect to the voting of the capital stock of the Company.

(g) The Company has no outstanding bonds, debentures, notes or other indebtedness, which have the right to vote on any matters on which stockholders may vote or which have the right to be converted into Company Common Stock or Company Preferred Stock.

2.4 Company Subsidiaries .

(a) Section 2.4(a) of the Company Disclosure Schedule sets forth the name of each Company Subsidiary, and with respect to each Company Subsidiary, (i) the jurisdiction in which each is incorporated or organized and (ii) the jurisdictions, if any, in which it is qualified to do business. All issued and outstanding shares or other equity interests of each Company Subsidiary are owned directly by the Company free and clear of any charges, liens, encumbrances, security interests or adverse claims. As used in this Agreement, “Company Subsidiary” means any corporation, partnership or other organization, whether incorporated or unincorporated, (i) of which the Company or any Company Subsidiary is a general partner or (ii) at least 50% of the securities or other interests having voting power to elect a majority of the board of directors or others performing similar functions with respect to such corporation, partnership or other organization are directly or indirectly owned or controlled by the Company or by any Company Subsidiary, or by the Company and one or more Company Subsidiaries.

(b) There are not as of the date of this Agreement, and at the Effective Time there will not be, any subscriptions, options, conversion or exchange rights, warrants, repurchase or redemption agreements, or other agreements or commitments of any nature whatsoever obligating any Company Subsidiary to issue, transfer, deliver or sell, or cause to be issued, transferred, delivered, sold, repurchased or redeemed, shares of the capital stock or other securities of the Company or any Company Subsidiary or obligating the Company or any Company Subsidiary to grant, extend or enter into any such agreement. To the knowledge of the Company, there are no stockholder agreements, voting trusts, proxies or other agreements, instruments or understandings with respect to the voting of the capital stock of any Company Subsidiary, other than as noted in Section 2.2 hereof.

(c) There are not as of the date of this Agreement any Company Joint Ventures. The term “Company Joint Venture” means any corporation or other entity (including partnerships, limited liability companies and other business associations) that is not a Company Subsidiary and in which the Company or one or more Company Subsidiaries owns an equity interest (other than equity interests held for passive investment purposes which are less than 10% of any class of the outstanding voting securities or other equity of any such entity).

2.5 SEC Reports; Sarbanes-Oxley Act . The Company previously has filed with the Securities and Exchange Commission (the “SEC”) its (i) Annual Report on Form 10-KSB for the year ended February 28, 2007 (the “Company 10-K”), as amended, (ii) its quarterly report on Form 10-QSB for its fiscal quarters ended November 30, 2007, August 31, 2007 and May 31, 2007, and (iii) all other documents required to be filed by the Company with the SEC under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) since March 1, 2005 (all such forms, reports, statements, certificates and other documents filed since March 1, 2005, including any amendments thereto, collectively, the “Company SEC Reports”). As of their respective filing dates, or, if amended or superseded by a subsequent filing made prior to the date of this Agreement, as of the date of the last such amendment or superseding filing prior to the date of this Agreement, the Company SEC Reports complied, and each of the Company SEC Reports filed by the Company between the date of this Agreement and the Closing Date will comply, in all material respects, with the Exchange Act and the Securities Act of 1933, as amended (the “Securities Act”), as the case may be. As of their respective filing dates, or, if amended or superseded by a subsequent filing made prior to the date of this Agreement, as of the date of the last such amendment or superseding filing prior to the date of this Agreement, the Company SEC Reports did not, or in the case of the Company SEC Reports filed by the Company on or after the date hereof will not, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, except to the extent that the information in such Company SEC Reports has been amended or superseded by a later Company SEC Report filed prior to the date of this Agreement. Since March 1, 2005, the Company has filed with the SEC all reports required to be filed by it under the Exchange Act. No Company Subsidiary is required to file any form, report or other document with the SEC. There are no outstanding loans or other extensions of credit made by the Company or any of the Company Subsidiaries to any executive officer (as defined in Rule 3b-7 under the Exchange Act) or director of the Company. The Company has not, since the enactment of the Sarbanes-Oxley Act, taken any action prohibited by Section 402 of the Sarbanes-Oxley Act. No executive officer of the Company has failed in any respect to make the certifications required of him or her under Section 302 or 906 of the Sarbanes-Oxley Act with respect to any Company SEC Report and to the Company’s knowledge the applicable executive officers anticipate making such certifications in the Company’s Annual Report on Form 10 KSB for the year ended February 29, 2008. The Company has made available to Parent true, correct and complete copies of all material written correspondence between the SEC, on the one hand, and the Company and any of the Company Subsidiaries, on the other hand since March 1, 2006. As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters received from the SEC staff with respect to the Company SEC Reports. To the knowledge of the Company, none of the Company SEC Reports is the subject of ongoing SEC review or outstanding SEC comment. None of the Company Subsidiaries is required to file periodic reports with the SEC pursuant to the Exchange Act.

2.6 Financial Statements . As of the dates on which they were filed or amended prior to the date of this Agreement in the Company SEC Reports filed prior to the date of this Agreement, the audited consolidated financial statements and unaudited consolidated interim financial statements of the Company included in such Company SEC Reports (i) were prepared in accordance with generally accepted accounting principles in all material respects applied on a consistent basis throughout the periods indicated (except as may be indicated in the notes thereto and except, in the case of the unaudited interim statements, as may be permitted under Form 10-QSB of the Exchange Act) and (ii) fairly presented, in all material respects (except as may be indicated in the notes thereto and subject, in the case of any unaudited interim financial statements, to normal year-end adjustments that would not be reasonably expected to be material in amount), the consolidated financial position, results of operations and cash flows of the Company and the consolidated Company Subsidiaries as of the respective dates thereof and for the respective periods indicated therein (subject, in the case of financial statements for any quarter of the current fiscal year, to normal year-end audit adjustments).

2.7 Absence of Undisclosed Liabilities . The Company has no material liabilities of any nature, whether accrued, absolute, contingent or otherwise, of a nature required by generally accepted accounting principles to be reflected in a consolidated balance sheet or disclosed in the notes thereto, other than liabilities (i) adequately reflected, accrued or reserved against on the Company Balance Sheet (as defined herein), (ii) included in Section 2.7 of the Company Disclosure Schedule, (iii) incurred since November 30, 2007, in the ordinary course of business consistent with past practice, or (iv) which have been discharged or paid in full prior to the date of this Agreement. The consolidated, unaudited balance sheet of the Company as of November 30, 2007 is referred to herein as the “Company Balance Sheet.”

2.8 Absence of Adverse Changes . Since February 28, 2007 through the date of this Agreement, except as contemplated by this Agreement, whether taken before or after the date of this Agreement (including any actions taken pursuant to the Plan (as defined herein)) (i) the Company and the Company Subsidiaries have conducted their respective businesses in all material respects in the ordinary course consistent with past practice and (ii) there has not been any change, event or circumstance that has had a Company Material Adverse Effect.

2.9 Compliance with Laws .

(a) The Company and each of the Company Subsidiaries have all required franchises, tariffs, grants, licenses, permits, easements, variances, exceptions, consents, certificates, clearances, accreditation, approvals, orders and authorizations of any Governmental Entity (defined in Section 2.9(b)) necessary for the Company and each of the Company Subsidiaries to operate and use their properties and assets and to conduct their businesses as presently operated, used and conducted (“ Company Permits ”) other than those the failure of which to possess would not have a Company Material Adverse Effect. Neither the Company nor any of the Company Subsidiaries has received written notice from any Governmental Entity or third party that any Company Permit is subject to any adverse action, including but not limited to, suspension, termination, revocation or withdrawal, except where the failure to have any such Company Permit or the receipt of such notice would not have or reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. The Company Permits are in full force and effect, except for any failures to be in full force and effect that, individually or in the aggregate, would not have or reasonably be expected to have a Company Material Adverse Effect. The Company and each of the Company Subsidiaries is in compliance with the terms of the Company Permits, as applicable, except for such failures to comply that, individually or in the aggregate, would not have or reasonably be expected to have a Company Material Adverse Effect.

(b) The Company and the Company Subsidiaries are not in violation of any federal, state, local or foreign law, ordinance or regulation or any order, judgment, injunction, decree or other requirement of any court, arbitral tribunal, administrative agency or commission or other governmental or other regulatory authority or agency, whether local, state, federal or foreign (a “ Governmental Entity ”), applicable to the Company or any of the Company Subsidiaries or by which its or any of their respective properties are bound, except for violations of any of the foregoing which would not, in the aggregate, reasonably be expected to have a Company Material Adverse Effect.

2.10 Actions and Proceedings . There are no outstanding orders, judgments, injunctions, decrees or other requirements of any Governmental Entity against the Company, any Company Subsidiary or any of their respective assets or properties, except for those that would not, individually or in the aggregate, have a Company Material Adverse Effect. There are no actions, suits or claims or legal, administrative or arbitration proceedings pending or, to the knowledge of the Company, threatened against the Company, any Company Subsidiary or any of their respective securities, assets or properties, other than any such suit, claim, action, proceeding, arbitration, mediation or investigation that would not, individually or in the aggregate, have a Company Material Adverse Effect.

2.11 Contracts and Other Agreements .

(a) Neither the Company nor any Company Subsidiary is a party to or bound by, and neither they nor their properties are subject to, any contract or other agreement required to be disclosed in a Form 10-KSB, Form 10-QSB or Form 8-K of the SEC, which is not so disclosed. All of such contracts and other agreements and all of the contracts required to be set forth in Section 2.11 of the Company Disclosure Schedule (“ Company Material Contracts ”) are valid, subsisting, in full force and effect, binding upon the Company or the Company Subsidiary party thereto, and, to the knowledge of the Company, binding upon the other parties thereto in accordance with their terms, except for such failures to be valid and binding or to be in full force and effect which would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect. There is no default under any Company Material Contract by the Company or any of the Company Subsidiaries and no event has occurred that with the lapse of time or the giving of notice or both would constitute a default thereunder by the Company or any Company Subsidiaries, in each case except as would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect. Correct and complete copies of the Company Material Contracts have been previously provided to Parent.

(b) Section 2.11(b) of the Company Disclosure Schedule sets forth a list of the following contracts and other agreements to which the Company or any Company Subsidiary is a party or by or to which they or their assets or properties are bound or subject:

(i) any agreement (A) relating to a joint venture, partnership or other arrangement involving a sharing of profits, losses, costs or liabilities with another person or entity, (B) providing for the payment or receipt by the Company or a Company Subsidiary of milestone payments or royalties, or (C) that individually requires aggregate expenditures by the Company and/or any Company Subsidiary in any one year of more than $50,000;

(ii) any indenture, trust agreement, loan agreement or note that involves or evidences outstanding indebtedness, obligations or liabilities for borrowed money in excess of $50,000;

(iii) any agreement of surety, guarantee or indemnification that involves potential obligations in excess of $50,000;

(iv) any agreement that limits or restricts the Company or any Company Subsidiary (or which, following the consummation of the Merger, could materially restrict the ability of the Surviving Corporation) to compete in any business or with any person or in any geographic area except for and any such Material Contract that may be canceled without any penalty or other liability to the Company or any of the Company Subsidiaries upon notice of 30 days or less;

(v) any interest rate, equity or other swap or derivative instrument; or

(vi) any agreement obligating the Company to register securities under the Securities Act.

(c) Except as disclosed on Section 2.11(c) of the Company Disclosure Schedule, no executive officer or director of the Company has (whether directly or indirectly through another entity in which such person has a material interest, other than as the holder of less than 1% of a class of securities of a publicly traded company) has any interest in any contract or property (real or personal, tangible or intangible), used in, or pertaining to the business of the Company which interest would be required to be disclosed pursuant to Item 404(a) of Regulation S-K promulgated by the SEC.

2.12 Properties .

(a) Except as would not have or reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company or one of the Company Subsidiaries, as applicable, has good title to all the properties and assets reflected in the latest audited balance sheet included in the Company SEC Reports as being owned by the Company or one of the Company Subsidiaries or acquired after the date thereof that are material to the Company’s business on a consolidated basis (except properties sold or otherwise disposed of since the date thereof in the ordinary course of business consistent with past practice), free and clear of all liens except Permitted Company Encumbrances. “Permitted Company Encumbrances” means (a) mechanics’, materialmen’s, carrier’s, repairer’s and other statutory liens arising or incurred in the ordinary course of business and that are not yet delinquent or are being contended in good faith; (b) liens for taxes assessments or other governmental charges not yet due and payable; (c) defects or imperfections of title in the nature of easements, covenants, conditions, encumbrances, restrictions, rights of way and similar matters affecting title as do not materially affect the use of the properties or assets subject thereto or affected thereby or otherwise materially impair business operations at such properties; (d) zoning, building codes and other land use laws regulating the use or occupancy of the Company Leased Property (defined in Section 2.12(b)) or the activities conducted thereon which are imposed by any Governmental Entity having jurisdiction over such Company Leased Property; and (e) mortgages, or deeds of trust, security interests or other encumbrances on title related to indebtedness reflected on the consolidated financial statements of the Company.

(b) Section 2.12(b) of the Company Disclosure Schedule sets forth a complete list as of the date of this Agreement of all material real property leased, subleased or licensed by the Company or any of the Company Subsidiaries (as lessor, sublessor, landlord, sublandlord or licensor, or lessee, sublessee, tenant, subtenant or licensee, as the case may be) (collectively, “ Company Leased Property ”) pursuant to which the Company or any of the Company Subsidiaries (and all of its and their sublessees and licensees) uses or occupies the Company Leased Property (all leases, subleases, licenses, sublicenses and other agreements with respect to such use or occupancy, including all master or ground leases), and all amendments, modifications and extensions thereof being referred to collectively as “Company Leases.” The Company has made available to the Parent correct and complete copies of all Company Leases and, to the knowledge of the Company, there are no material oral agreements, promises or understandings with respect to any Company Leased Property, which is subject to a Company Lease.

(c) Except as would not have or reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (A) each Company Lease is valid and binding on the Company or the Company Subsidiary party thereto and, to the knowledge of the Company, each other party thereto, and is in full force and effect; (B) there is no breach or default under any Lease by the Company or the Company Subsidiary party thereto or, to the knowledge of the Company, any other party thereto, and neither the Company nor any of the Company Subsidiaries has received any written communication from, or given any written communication to, any other party to the Company Lease or any lender, alleging that the Company or any of the Company Subsidiaries or such other party, as the case may be, is or may be in default (and no event has occurred that with or without the lapse of time or the giving of notice or both would constitute a breach or default under any Company Lease by the Company or any of the Company Subsidiaries or, to the knowledge of the Company, any other party thereto); and (C) the Company or the Company Subsidiary party to each Company Lease has a good and valid leasehold interest in each parcel of real property which is subject to a Company Lease, free and clear of all liens except Permitted Company Encumbrances, and is in possession of the properties purported to be leased or licensed thereunder.

(d) None of the Company or any of the Company Subsidiaries owns any real property or has any options or rights or obligations to purchase, rights of first refusal, rights of first negotiation or rights of first offer to purchase, any real property.

2.13 Intellectual Property .

(a) Schedule 2.13 of the Company Disclosure Schedule sets forth a complete and accurate list as of the date of this Agreement of all material patents and patent applications; registered trademarks, service marks and trade names; registered domain names; and registered copyrights that are owned by the Company or any of the Company Subsidiaries and used by the Company or any of its Subsidiaries in the business of the Company and the Company Subsidiaries.

(b) Except as set forth on Section 2.13 of the Company Disclosure Schedule:

(i) except as would not have or reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, to the knowledge of the Company, the Company and/or the Company Subsidiaries (A) exclusively own the Company Intellectual Property, or (B) license, sublicense or otherwise possess legally enforceable rights to use all Company Intellectual Property that it does not so own, in the case of the foregoing clauses (A) and (B) above, free and clear of all Liens granted by the Company, other than Permitted Liens, and as are reasonably necessary for their businesses as currently conducted;

(ii) to the knowledge of the Company, neither the operation of the business of the Company or any of the Company Subsidiaries, nor any activity of the Company or any of the Company Subsidiaries conflicts with, infringes upon or misappropriates any Intellectual Property of any third party;

(iii) to the knowledge of the Company, the Company Intellectual Property is not being infringed or misappropriated by any third party.

(iv) the Company and the Company Subsidiaries have taken reasonable measures and efforts to protect and maintain the confidentiality of any know-how, trade secrets, confidential information or proprietary information owned by the Company or any of the Company Subsidiaries;

(v) the Company and the Company Subsidiaries are not a party to any claim, suit or other action, and to the knowledge of the Company, no claim, suit or other action is threatened against any of them, that challenges the validity, enforceability or ownership of, or the right to use, sell or license the Company Intellectual Property and, no third party has alleged in writing during the two (2) year period prior to the date hereof that any of the operation of the Company Intellectual Property, the operation of the business of the Company or any of the Company Subsidiaries, or any activity of the Company or any of the Company Subsidiaries conflicts with, infringes upon or misappropriates any Intellectual Property of any third party;

(vi) except as would not have or reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, no current or former employee or consultant of the Company or any of its Subsidiaries owns any material rights in or to any Intellectual Property created in the scope of such employee’s employment or consultant’s engagement by, as applicable, with the Company or any of the Company Subsidiaries;

(vii) except as would not have or reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the transactions contemplated by this Agreement will not adversely affect the Company’s or the Company Subsidiaries’ or the Surviving Corporation’s right, title and interest in and to the Company Intellectual Property; and

(viii) all patents, patent applications and registrations for trademarks, service marks and copyrights which are held by the Company or any of the Company Subsidiaries and which are material to the business of the Company and the Company Subsidiaries, taken as a whole, as currently conducted, are subsisting, have been duly maintained (including the payment of maintenance fees), and have not expired or been cancelled.

(i) “ Intellectual Property ” means (i) rights in patents, inventions, copyrights in both published and unpublished works, works of authorship, software, trademarks, service marks, domain names, trade dress, trade secrets, (ii) registrations and applications to register any of the foregoing in any jurisdiction, (iii) processes, formulae, methods, schematics, technology, know-how, computer software programs and applications, (iv) other tangible or intangible proprietary or confidential information and materials, and (v) any and all other intellectual property rights and/or proprietary rights relating to any of the foregoing.

(ii) “ Company Intellectual Property ” means all Intellectual Property owned by the Company or any of the Company Subsidiaries or used by the Company or any of the Company Subsidiaries in the business of the Company and the Company Subsidiaries.

2.14 Insurance . Section 2.14 of the Company Disclosure Schedule sets forth a true and correct list of all material insurance policies and binders held by or on behalf of the Company and the Company Subsidiaries. Such policies and binders (i) are in full force and effect, (ii) are in material conformity with the requirements of all leases or other agreements to which the Company or the relevant Company Subsidiary is a party and (iii) to the knowledge of the Company, are valid and enforceable in accordance with their terms, except where the failure to be valid and enforceable would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect. Neither the Company nor any Company Subsidiary is in material default with respect to any provision contained in such policy or binder nor has any of the Company or a Company Subsidiary failed to give any notice or present any claim under any such policy or binder in due and timely fashion. There are no material outstanding unpaid claims under any such policy or binder. As of the date of this Agreement, neither the Company nor any Company Subsidiary has received written notice of cancellation or non-renewal of any such policy or binder.

2.15 Tax Matters . Except as set forth in Section 2.15 of the Company Disclosure Schedule:

(a) For purposes of this Agreement, the term “ Tax ” (and, with correlative meaning, “Taxes” and “Taxable”) means all United States federal, state, and local, and all foreign, income, profits, franchise, gross receipts, payroll, custom chattels, transfer, sales, employment, use, property, excise, value added, ad valorem, estimated, stamp, alternative or add-on minimum, recapture, environmental, withholding and any other taxes, charges, duties, impositions or assessments of any kind whatsoever, together with all interest, penalties, and additions imposed on or with respect to such amounts, including any liability for taxes of a predecessor entity. “ Tax Return ” means any return, declaration, report, claim for refund, or information return or statement filed or required to be filed with any taxing authority in connection with the determination, assessment, collection or imposition of any Taxes.

(b) All Tax Returns required to be filed on or before the date hereof by or with respect to the Company and the Company Subsidiaries have been filed within the time and in the manner prescribed by law. All such Tax Returns are true, correct and complete in all material respects, and all Taxes owed by the Company or the Company Subsidiaries, whether or not shown on any Tax Return, have been paid. The Company and the Company Subsidiaries file Tax Returns in all jurisdictions where they are required to so file, and no claim has ever been made by any taxing authority in any other jurisdiction that the Company or the Company Subsidiaries are or may be subject to taxation by that jurisdiction.

(c) There are no liens or other encumbrances with respect to Taxes upon any of the assets or properties of the Company or the Company Subsidiaries, other than with respect to Taxes not yet due and payable.

(d) No audit is currently pending with respect to any Tax Return of the Company or the Company Subsidiaries. No deficiency for any Taxes has been proposed in writing against the Company or the Company Subsidiaries, which deficiency has not been paid in full.

(e) There are no outstanding agreements, waivers or arrangements extending the statutory period of limitation applicable to any claim for, or the period for the collection or assessment of, Taxes due from or with respect to the Company or the Company Subsidiaries for any taxable period. The Company has delivered to Parent complete and correct copies of all income Tax Returns, audit reports and statements of deficiencies for each of the last three taxable years filed by or issued to or with respect to the Company or the Company Subsidiaries.

(f) With respect to any period for which Tax Returns have not yet been filed, or for which Taxes are not yet due or owing, the Company has, in accordance with generally accepted accounting principles, made due and sufficient accruals for such Taxes in the Company’s books and records.

(g) Each of the Company and the Company Subsidiaries has withheld and paid all Taxes required to have been withheld and paid in connection with amounts paid or owing to any employee, independent contractor, creditor, stockholder, or other third party, and all Form W-2 and 1099 or corresponding foreign reports required with respect thereto have been properly completed and timely filed.

(h) Other than with respect to the consolidated group of which the Company is the parent, the Company and the Company Subsidiaries are not and have never been a party to or bound by, nor do they have or have they ever had any obligation under, any Tax sharing agreement or similar contract or arrangement. Other than with respect to the consolidated group of which the Company is the parent, neither the Company nor any Company Subsidiary has any liability for the Taxes of any other person under Treasury Regulation 1.1502-6 (or any similar provision of state, local or foreign law), as a transferee or successor, by contract, or otherwise.

(i) Neither the Company nor any Company Subsidiary has agreed to, or is required to, make any adjustments under Section 481(a) of the Code by reason of a change in accounting method or otherwise.

(j) Neither the Company nor the Company Subsidiaries are, or were during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code, a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code.

(k) The Company has made available to Parent correct and complete copies of all state sales and use Tax Returns filed for the Company and each of the Company Subsidiaries and each of the Company’s and the Company Subsidiaries’ predecessor entities, if any, filed since December 31, 2004. The Company has also made available to Parent correct and complete copies of all material examination reports received and all statements of deficiencies assessed against, or agreed to, by the Company or any of the Company Subsidiaries or their predecessor entities with respect to such Tax Returns described in the preceding sentence.

(l) Neither the Company nor any of the Company Subsidiaries will be required to include any item of income in, or exclude any item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any:

(i) change in method of accounting for a taxable period ending on or prior to the Closing Date;

(ii) “closing agreement” as described in Section 7121 of the Code (or any corresponding or similar provision of state, local or foreign income Tax law) executed on or prior to the Closing Date;

(iii) intercompany transactions or any excess loss account described in Treasury Regulations under Section 1502 of the Code (or any corresponding or similar provision of state, local or foreign income Tax law);

(iv) installment sale or open transaction disposition made on or prior to the Closing Date; or

(v) prepaid amount received on or prior to the Closing Date.

2.16 Employee Benefit Plans .

(a) Section 2.16(a) of the Company Disclosure Schedule contains a correct and complete list identifying each “employee benefit plan,” as defined in Section 3(3) of ERISA (whether or not subject to ERISA), each employment, consultancy, non-compete, severance, termination, change of control, or similar agreement, contract, plan, arrangement or policy and each other contract, plan, arrangement or policy providing for compensation, bonuses, profit-sharing, stock purchase, stock option or other stock-related rights or other forms of incentive or deferred compensation, fringe benefits, vacation benefits, insurance (including any self-insured arrangements), health or medical benefits, employee assistance program, disability or sick leave benefits, workers’ compensation, supplemental unemployment benefits, severance benefits and post-employment or retirement benefits (including compensation, pension, health, medical or life insurance benefits and any summary plan descriptions) which covers any current employee or former employee, director or consultant of the Company or the Company Subsidiaries or its ERISA Affiliates or any of their dependents, with respect to which the Company or any of its ERISA Affiliates has any material liability, whether current or contingent (individually, a “ Company Employee Plan ” and collectively, the “ Company Employee Plans ”). A copy of each such Company Employee Plan (and, if applicable, related trust or funding agreements or insurance policies) and all amendments thereto or a description of each Company Employee Plan that is unwritten, has been made available to Parent together with the most recent annual report (Form 5500 including, where applicable, all schedules and actuarial and accountants’ reports) and Tax Return (Form 990) prepared in connection with any such plan or trust.

(b) Section 2.16(b) of the Company Disclosure Schedule contains a list of all severance payments payable by the Company in connection with the termination of any current employee or consultant of the Company or any Company Subsidiary, including any amounts, to the Company's knowledge, arising under statutory obligations and any applicable notice periods.

(d) No Company Employee Plan is a multiemployer plan, as defined in Section 3(37) of ERISA (a “ Multiemployer Plan ”), or a multiple employer welfare arrangement as defined in Section 3(40) of ERISA (a “ MEWA ”) or a multiple employer plan as defined in Section 413(c) of the Code. Neither the Company, any of the Company Subsidiaries nor any of their ERISA Affiliates has (i) ever been obligated to contribute to a “multiemployer plan” (as defined in Section 4001(a)(3) of ERISA); or (ii) to the knowledge of the Company, ever maintained a Company Employee Plan which was ever subject to the laws of any jurisdiction outside of the United States.

(e) Except as has not and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each Company Employee Plan that is intended to be qualified under Section 401(a) of the Code (each, a “ Company Qualified Plan ”) is so qualified and the plan as currently in effect has received a favorable determination or opinion letter to that effect from the Internal Revenue Service, no such determination or opinion letter has been revoked and revocation has not been threatened, and to the Company’s knowledge, there is no reason why any such determination or opinion letter should be revoked or not be reissued. The Company has made available to Parent copies of the most recent Internal Revenue Service determination or opinion letters with respect to each such Company Qualified Plan. Each Company Employee Plan has been maintained in compliance with its terms and with the requirements prescribed by any and all statutes, orders, rules and regulations, including ERISA and the Code, which are applicable to such Company Employee Plan with such exceptions as would not have or be reasonably expected, individually or in the aggregate, to have a Company Material Adverse Effect. Each Company Employee Plan that is a “nonqualified deferred compensation plan” within the meaning of Section 409A(d)(l) of the Code and any award thereunder, in each case that is subject to Section 409A of the Code, has been operated in good faith compliance in all material respects with Section 409A of the Code and the regulations, guidance and notices issued thereunder. The Company has complied in all material respects with the reporting and wage withholding requirements under Section 409A of the Code and applicable IRS guidance. No events have occurred with respect to any Company Employee Plan that could result in payment or assessment by or against the Company or any of its ERISA Affiliates of any excise Taxes under Sections 4972, 4975,4976, 4977,4979, 4980B, 4980D, 4980E or 5000 of the Code or any penalty or tax under Section 5.02(i) of ERISA except for any such payment or assessment as would not be reasonably expected, individually or in the aggregate, to have a Company Material Adverse Effect.

(f) There is no current or projected liability in respect of post-employment or post-retirement health or medical or life insurance benefits or other retiree benefits for any person, retired, former or current employees of the Company or the Company Subsidiaries, except as required by applicable law or under Section 4980B of the Code (“COBRA”). No condition exists that would prevent the Company or any of its ERISA Affiliates from amending or terminating any Company Employee Plan providing health or medical benefits in respect of any current or former employees of the Company or the Company Subsidiaries. None of the Company, any of the Company Subsidiaries, or any Company Employee Plans promises or provides retiree medical or other retiree welfare benefits to any person, except as required by applicable law and there has been no communication to current or former employees by the Company or any of the Company Subsidiaries which could reasonably be interpreted to promise or guarantee such employees retiree health or life insurance or other retiree death benefits on a permanent basis.

(g) All contributions and payments due under each Company Employee Plan, determined in accordance with GAAP, as adjusted to include proportional accruals for the period ending on the Effective Time, will be discharged and paid on or prior to the Effective Time except to the extent accrued as a liability in accordance with ordinary Company practice. There has been no amendment to, written interpretation of or announcement (whether or not written) by the Company or any of its ERISA Affiliates relating to, or change in employee participation or coverage under, any Company Employee Plan which would increase materially the expense of maintaining such Company Employee Plan above the level of the expense incurred in respect thereof for the most recent fiscal year ended prior to the date hereof. With respect to each Company Employee Plan, there are no benefit obligations for which contributions have not been made or properly accrued to the extent required by GAAP on the Company’s financial statements.

(h) Section 2.16(h) of the Company Disclosure Schedule lists all contracts and agreements between the Company and David C. McCourt.

(i) No employee, consultant or former consultant or employee of the Company or any of the Company Subsidiaries will become entitled to any bonus, retirement, severance, job security or similar benefit, or the enhancement of any such benefit or any other payment, as a result of the transactions contemplated hereby alone or together with any other event. Except as set forth on Section 2.16(i) of the Company Disclosure Schedule, neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby could (either alone or in conjunction with any other event) result in, or cause the accelerated vesting, funding or delivery of, or increase the amount or value of, any payment or benefit to any employee, officer or director of the Company or any of the Company Subsidiaries, or could limit the right of the Company or any of the Company Subsidiaries to amend, merge, terminate or receive a reversion of assets from any Company Employee Plan or related trust. There is no Contract, plan or arrangement (written or otherwise) covering any employee or former employee of the Company or any of the Company Subsidiaries that, individually or collectively, could give rise to the payment of any amount that would not be deductible pursuant to the terms of Sections 280G or 162(m) of the Code, as a result of the transactions contemplated hereby alone or together with any other event. The information set forth on Section 2.16(g)(ii) of the Company Disclosure Schedule regarding severance arrangements for certain executive officers and certain other executives of the Company is true and correct in all material respects.

(j) No “prohibited transactions” within the meaning of Section 4975 of the Code or Sections 406 and 407 of ERISA, that are not otherwise exempt under Section 408 of ERISA, has occurred with respect to any Company Employee Plan. There is no material action, suit, investigation, audit, arbitration or proceeding (i) pending against or involving or, to the knowledge of the Company, threatened against any Company Employee Plan or (ii) involving the Company’s classification of individuals as either employees or independent contractors, in each case, before any arbitrator or any Governmental Entity.

(k) There is no material action, suit, investigation, audit, arbitration or proceeding (i) pending against or involving or, to the knowledge of the Company, threatened against any Company Employee Plan, (ii) pending or, to the knowledge of the Company, threatened involving the Company’s or any of the Company Subsidiaries’ classification of individuals as either employees or independent contractors, (iii) pending or, to the knowledge of the Company, threatened involving the Company’s or any of the Company Subsidiaries’ classification of Employees as exempt or non-exempt for purposes of wage and hour laws, rules or regulations, or (iv) pending or, to the knowledge of the Company, threatened under any workers compensation policy or long-term disability policy, in each case, before or by any arbitrator or any Governmental Entity other than routine claims for benefits payable under any such policy.

2.17 Employee Relations .

(a) The Company and the Company Subsidiaries, collectively, have the employees and consultants listed on Schedule 2.17 of the Company Disclosure Schedule. Neither the Company nor any Company Subsidiary is delinquent in payments to any of its employees or consultants for any wages, salaries, commissions, bonuses or other direct compensation for any services performed by them or amounts required to be reimbursed to such employees. Except as disclosed in Section 2.17 of the Company Disclosure Schedule, upon termination of the employment of any employees, none of the Company, the Company Subsidiaries nor Parent shall be liable, by reason of the Merger or anything done prior to the Effective Time, to any of such employees for severance pay or any other payments (other than their accrued salary, vacation or sick pay in accordance with normal policies). Schedule 2.17 of the Company Disclosure Schedule list all current directors, officers, employees and consultants of the Company and the Company Subsidiaries including, in each case, name, current job title and annual rate of base compensation, minimum employment or contract terms and termination notice requirement.

(b) The Company and each Company Subsidiary (i) is in compliance in all material respects with all applicable foreign, federal, state and local laws, rules and regulations respecting employment, employment practices, terms and conditions of employment and wages and hours, in each case, with respect to employees, (ii) has withheld all amounts required by law or by agreement to be withheld from the wages, salaries and other payments to employees, (iii) is not liable for any arrears of wages or any taxes or any penalty for failure to comply with any of the foregoing, and (iv) is not liable for any payment to any trust or other fund or to any Governmental Entity, with respect to unemployment compensation benefits, social security or other benefits or obligations for employees (other than routine payments to be made in the ordinary course of business and consistent with past practice), except in each case of clauses (i) through (iv) where the failure or liability would not be reasonably expected to have a Company Material Adverse Effect.

(c) No work stoppage or labor strike against the Company or any Company Subsidiary is pending or, to the knowledge of the Company, threatened. Neither the Company nor any Company Subsidiary is involved in or, to the knowledge of the Company, threatened with, any labor dispute, grievance, or litigation relating to labor, safety or discrimination matters involving any employee, including without limitation charges of unfair labor practices or discrimination complaints, that, if adversely determined, would result in material liability to the Company. Neither the Company nor any Company Subsidiary has engaged in any unfair labor practices within the meaning of the National Labor Relations Act or any similar foreign law that would, directly or indirectly result in material liability to the Company. Neither the Company nor any Company Subsidiary is presently, nor has it been in the past, a party to or bound by any collective bargaining agreement or union contract with respect to employees other than as set forth in Section 2.17 of the Company Disclosure Schedule and no collective bargaining agreement is being negotiated by the Company or any Company Subsidiary. No union organizing campaign or activity with respect to non-union employees of the Company or any Company Subsidiary is ongoing, pending or, to the knowledge of the Company, threatened.

2.18 No Breach . Except as set forth in Section 2.18 of the Company Disclosure Schedule, the execution, delivery and performance of this Agreement by the Company and the consummation by the Company of the transactions contemplated hereby will not (i) violate any provision of the Certificate of Incorporation or By-Laws of the Company, (ii) result in a violation or breach of or the loss of any benefit under, or constitute (with or without due notice or lapse of time or both) a default (or give rise to any right of termination, amendment, cancellation or acceleration) under any instrument, contract or other agreement to which the Company or any Company Subsidiary is a party or to which any of them or any of their assets or properties is bound or subject, (iii) assuming that all consents, approvals, authorizations and other actions described in subsection (v) have been obtained and all filings and obligations in subsection (v) have been made or complied with, violate any law, ordinance or regulation or any order, judgment, injunction, decree or other requirement of any Governmental Entity applicable to the Company or the Company Subsidiaries or by which any of the Company’s or the Company Subsidiaries’ assets or properties is bound, (iv) violate any Permit, (v) require any filing with, notice to, or permit, consent or approval of, any Governmental Entity, except for (A) compliance with any applicable requirements of the Exchange Act, (B) any filings as may be required under the DGCL in connection with the Merger or (C) any filings with the SEC or the NASDAQ Stock Market, (vi) result in the creation of any lien or other encumbrance on the assets or properties of the Company or a Company Subsidiary, or (vii) cause any of the assets owned by the Company or any Company Subsidiary to be reassessed or revalued by any taxing authority or other Governmental Entity, excluding from clauses (ii) through (vi) where (x) any such violations, breaches, defaults or encumbrances, (y) any failure to obtain such permits, authorizations, consents or approvals, or (z) any failure to make such filings, would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect or materially interfere with the ability of the Company to consummate the transactions contemplated hereby.

2.19 Board Approvals; Takeover Statutes .

(a) At a meeting duly called and held, the Company’s Board of Directors unanimously (i) approved and adopted the Agreement and declared its advisability in accordance with the provisions of the DGCL; (ii) determined that the terms of the Merger and the other transactions contemplated by this Agreement are fair and in the best interests of the Company and the Company’s shareholders; and (iii) directed, subject to Section 4.4(c) , that this Agreement be submitted to the Company’s shareholders for their adoption and resolved to recommend that the shareholders vote in favor of the adoption of this Agreement.

(b) Assuming the accuracy of the representations and warranties of Parent and Merger Sub set forth in Sections 3.22 and 3.23, no “fair price”, “moratorium”, “control share acquisition” or other similar anti-takeover statute or regulation enacted under state or federal laws in the United States applicable to the Company is applicable to the Merger or the other transactions contemplated hereby.

2.20 Financial Advisor .

(a) The Board of Directors of the Company has received the opinion of Houlihan Smith & Company Inc. (“ Houlihan ”), dated on or about the date of this Agreement, to the effect that, as of such date, the Merger Consideration is fair, from a financial point of view, to the holders of Company Common Stock, a copy of which opinion has been made available to Parent.

(b) No broker, finder, agent or similar intermediary has acted on behalf of the Company in connection with this Agreement or the transactions contemplated hereby, and there are no brokerage commissions, finders’ fees or similar fees or commissions payable in connection herewith based on any agreement, arrangement or understanding with the Company, or any action taken by the Company.

2.21 Proxy Statement and Registration Statement . None of the information supplied or to be supplied by the Company for inclusion or incorporation by reference in the Registration Statement (as defined herein) and the Joint Proxy Statement/Prospectus (as defined herein) will, (i) at the time it is declared effective under the Securities Act, (ii) at the time the Joint Proxy Statement/Prospectus (or any amendment or supplement thereto) is first mailed to the stockholders of the Company, (iii) at the time of the Company Stockholders’ Meeting, and (iv) at the Effective Time (with respect to the Registration Statement only), contain any untrue statement of material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which it is made, not false or misleading. If at any time prior to the Effective Time any event or circumstance relating to the Company or any Company Subsidiaries, or their respective officers and directors, should be discovered by the Company which should be set forth in an amendment or supplement to the Registration Statement or Joint Proxy Statement/Prospectus, the Company shall promptly inform Parent. Notwithstanding the foregoing, the Company makes no representation or warranty with respect to information supplied by Parent or any of its representatives, which is contained in the Registration Statement or the Joint Proxy Statement/Prospectus. All documents that the Company is responsible for filing with the SEC in connection with the transactions contemplated by this Agreement shall comply in all material aspects with the applicable requirements of the Securities Act and the rules and regulations promulgated thereunder and the Exchange Act and the rules and regulations promulgated thereunder.

ARTICLE III - REPRESENTATIONS AND WARRANTIES

OF PARENT AND MERGER SUB

Except as set forth on Schedule D delivered by Parent to the Company on the date hereof (the “ Parent Disclosure Schedule ”), the section numbers of which are numbered to correspond to the section numbers of this Agreement to which they refer, it being agreed that disclosure of any item in any section of the Parent Disclosure Schedule shall also be deemed disclosure with respect to any other section of this Agreement to which the relevance of such item is reasonably apparent, Parent and Merger Sub hereby make the following representations and warranties to the Company:

3.1 Organization and Qualification .

(a) Each of Parent and each Parent Subsidiary (as defined in Section 3.4(a)) is a corporation or other legal entity duly organized, validly existing and in good standing (with respect to jurisdictions that recognize the concept of good standing) under the laws of its jurisdiction of organization and has corporate or similar power and authority to own, lease and operate its assets and to carry on its business as now being conducted, except where any such failure to have such power or authority would not, individually or in the aggregate, have a Parent Material Adverse Effect (as defined herein). Each of Parent and each Parent Subsidiary is qualified or otherwise authorized to transact business as a foreign corporation or other organization in all jurisdictions in which such qualification or authorization is required by law, except for jurisdictions in which the failure to be so qualified or authorized would not reasonably be expected to have a Parent Material Adverse Effect. “Parent Material Adverse Effect” means any fact, circumstance, event, change, effect or occurrence that, individually or in the aggregate with all other facts, circumstances, events, changes, effects, or occurrences, has or would be reasonably expected to have a material adverse effect on or with respect to the business, results of operation or financial condition of Parent and the Parent Subsidiaries taken as a whole, provided, however, that a Parent Material Adverse Effect shall not include facts, circumstances, events, changes, effects or occurrences (i) generally affecting the economy or the financial, debt, credit or securities markets in the United States, including as a result of changes in geopolitical conditions, (ii) generally affecting any of the industries in which Parent or the Parent Subsidiaries operate, (iii) resulting from the announcement of this Agreement, (iv) resulting from changes in any applicable laws or regulations or applicable accounting regulations or principles or interpretations thereof, (v) resulting from any actions taken pursuant to or in accordance with the terms of this Agreement, (vi) resulting from any outbreak or escalation of hostilities or war or any act of terrorism, (vii) resulting from any failure by the Parent to meet its internal or published projections, budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations, in and of itself (it being understood that the facts or occurrences giving rise or contributing to such failure that are not otherwise excluded from the definition of a “Parent Material Adverse Effect” may be taken into account in determining whether there has been a Parent Material Adverse Effect), or (viii) resulting from a decline in the price of the Parent Common Stock on the NASDAQ Capital Market (it being understood that the facts or occurrences giving rise or contributing to such decline that are not otherwise excluded from the definition of a “Parent Material Adverse Effect” may be taken into account in determining whether there has been a Parent Material Adverse Effect).

Parent has previously provided or made available to the Company true, correct and complete copies of the charter and bylaws or other organizational documents of Parent and each Parent Subsidiary as in effect on the date of this Agreement, and none of Parent or any Parent Subsidiary is in violation of any provisions of such documents, except as would not reasonably be expected to have a Parent Material Adverse Effect.

3.2 Authority to Execute and Perform Agreements . The Parent and the Merger Sub each have the corporate power and authority to enter into, execute and deliver this Agreement, and, subject to receipt of the Parent Requisite Vote (as defined herein), to perform its obligations hereunder and to consummate the transactions contemplated hereby. Each of (i) the Board of Directors of Parent and (ii) the Board of Directors of the Merger Sub, has duly authorized the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby and immediately after the execution and delivery of this Agreement, Parent, as sole stockholder of Merger Sub, will approve and adopt this Agreement. No other corporate proceeding on the part of the Parent or Merger Sub is necessary to consummate the transactions contemplated hereby other than the approval of the Charter Amendment, the Share Issuance and the CVR Issuance by the requisite holders of Parent Common Stock (and the filing with the Secretary of State of the State of Delaware of the Certificate of Merger as required by the DGCL). This Agreement has been duly executed and delivered by Parent and the Merger Sub and, assuming the due authorization, execution and delivery by the Company, constitutes a valid and binding obligation of Parent and Merger Sub, enforceable against Parent and the Merger Sub in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other similar Laws relating to creditors’ rights generally and to general principles of equity. The only vote of Parent stockholders required to approve (i) the Charter Amendment is an affirmative votes of a number of outstanding shares of Parent Common Stock in favor of the Charter Amendment that exceeds the number of votes of outstanding shares of Parent Common Stock against the Charter Amendment and (ii) the Share Issuance and the CVR Issuance is the affirmative vote of a majority of the votes cast by outstanding shares of Parent Common Stock (the requisite votes to approve required by clauses (i) and (ii) collectively, the “Parent Requisite Vote”).

3.3 Capitalization and Title to Shares .

(a) The authorized capital stock of Parent consists of (i) 75,000,000 shares of Parent Common Stock and (ii) 5,000,000 shares of preferred stock, par value $0.0001 per share (“ Parent Preferred Stock ”), of which 700,000 shares are currently designated Series A-10 Preferred Stock. As of May 9, 2008, (A) 42,343,326 shares of Parent Common Stock were issued and outstanding and (B) 74,841 shares of Series A-10 Preferred Stock, convertible into 748,410 shares of Parent Common Stock, were issued and outstanding. All of the issued and outstanding shares of Parent’s Common Stock and Parent’s Preferred Stock are duly authorized, validly issued, fully paid, nonassessable and free of preemptive rights.

(b) The Parent has reserved 14,646,528 shares of Parent Common Stock for issuance pursuant to all of the options to purchase Parent Common Stock issued or issuable pursuant to Parent's stock option and similar plans (the "Parent Options"). As of March 31, 2008, Parent Options to purchase 11,806,528 shares of Parent Common Stock were outstanding. Section 3.3 (b) of the Parent Disclosure Schedule sets forth with respect to each Parent Option outstanding as of March 31, 2008, (i) the number of shares of Parent Common Stock issuable therefor and (ii) the purchase price payable therefor upon the exercise of each such Parent Option. True and complete copies of all instruments (or the forms of such instruments) referred to in this Section 3.3 (b) have been furnished previously to Company. Except as indicated in Section 3.3 (b) of the Parent Disclosure Schedule, Parent is not obligated to accelerate the vesting of any Parent Options as a result of the Merger.

(c) As of March 31, 2008, warrants to purchase 2,857,535 shares of Parent Common Stock were outstanding (“ Parent Warrants ”). Section 3.3(c) of the Parent Disclosure Schedule includes a true and complete list of all outstanding Parent Warrants.

(d) Except for (i) shares indicated as issued and outstanding on March 31, 2008 in Section 3.3(a), and (ii) shares issued after March 31, 2008, upon (A) the exercise of outstanding Parent Options listed in Section 3.3(b) of the Parent Disclosure Schedule; (B) the exercise of outstanding Parent Warrants listed in Section 3.3(c) of the Parent Disclosure Schedule; or (C) the exercise of other outstanding convertible securities or other agreement to issue Parent Common Stock listed on Section 3.3(e) of the Parent Disclosure Schedule, there are not as of the date hereof, and at the Effective Time, except as set forth in Section 3.3(e) of the Parent Disclosure Schedule, there will not be, any shares of Parent Common Stock issued and outstanding.

(e) Other than Parent Options listed in Section 3.3(b) of the Parent Disclosure Schedule and the Parent Warrants listed in Section 3.3(d) of the Parent Disclosure Schedule, and except as set forth in Section 3.3(e) of the Parent Disclosure Schedule, there are not, as of the date of this Agreement, authorized or outstanding any subscriptions, options, conversion or exchange rights, warrants, repurchase or redemption agreements, or other agreements or commitments of any nature whatsoever obligating Parent to issue, transfer, deliver or sell, or cause to be issued, transferred, delivered, sold, repurchased or redeemed, additional shares of the capital stock or other securities of Parent or obligating Parent to grant, extend or enter into any such agreement. Except as set forth in Section 3.3(e) of the Parent Disclosure Schedule, to the knowledge of Parent, there are no stockholder agreements, voting trusts, proxies or other agreements, instruments or understandings with respect to the voting of the capital stock of the Company.

(f) The Parent has no outstanding bonds, debentures, notes or other indebtedness, which have the right to vote on any matters on which stockholders may vote.

3.4 Parent Subsidiaries .

(a) Section 3.4(a) of the Parent Disclosure Schedule sets forth the name of each Parent Subsidiary, and with respect to each Parent Subsidiary, (i) the jurisdiction in which each is incorporated or organized and (ii) the jurisdictions, if any, in which it is qualified to do business. All issued and outstanding shares or other equity interests of each Parent Subsidiary are owned directly by the Parent free and clear of any charges, liens, encumbrances, security interests or adverse claims. As used in this Agreement, “ Parent Subsidiary ” means any corporation, partnership or other organization, whether incorporated or unincorporated, (i) of which the Parent or any Parent Subsidiary is a general partner or (ii) at least 50% of the securities or other interests having voting power to elect a majority of the board of directors or others performing similar functions with respect to such corporation, partnership or other organization are directly or indirectly owned or controlled by the Parent or by any Parent Subsidiary, or by the Parent and one or more Parent Subsidiaries.

(b) There are not as of the date of this Agreement, and at the Effective Time there will not be, any subscriptions, options, conversion or exchange rights, warrants, repurchase or redemption agreements, or other agreements, claims or commitments of any nature whatsoever obligating any Parent Subsidiary to issue, transfer, deliver or sell, or cause to be issued, transferred, delivered, sold, repurchased or redeemed, shares of the capital stock or other securities of the Parent or any Parent Subsidiary or obligating the Parent or any Parent Subsidiary to grant, extend or enter into any such agreement. To the knowledge of the Parent, there are no stockholder agreements, voting trusts, proxies or other agreements, instruments or understandings with respect to the voting of the capital stock of any Parent Subsidiary, other than as noted in Section 3.2 hereof.

(c) Section 3.4(c) of the Parent Disclosure Schedule sets forth, for each Parent Joint Venture, the interest held by the Parent and the jurisdiction in which such Parent Joint Venture is organized. Interests in Parent Joint Ventures held by the Parent are held directly by the Parent, free and clear of any charges, liens, encumbrances, security interest or adverse claims. The term “Parent Joint Venture” means any corporation or other entity (including partnerships, limited liability companies and other business associations) that is not a Parent Subsidiary and in which the Parent or one or more Parent Subsidiaries owns an equity interest (other than equity interests held for passive investment purposes which are less than 10% of any class of the outstanding voting securities or other equity of any such entity).

3.5 SEC Reports; Sarbanes-Oxley Act . Parent previously has filed with the SEC its (i) Annual Report on Form 10-KSB for the year ended September 30, 2007 (the “Parent 10-K”), as amended, (ii) its quarterly report on Form 10-QSB for its fiscal quarters ended December 31, 2007 and March 31, 2008, and (iii) all other documents required to be filed by Parent with the SEC under the Exchange Act since October 1, 2006 (all such forms, reports, statements, certificates and other documents filed since October 1, 2006, including any amendments thereto, collectively, the “Parent SEC Reports”). As of their respective filing dates, or, if amended or superseded by a subsequent filing made prior to the date of this Agreement, as of the date of the last such amendment or superseding filing prior to the date of this Agreement, the Parent SEC Reports complied, and each of the Parent SEC Reports filed by Parent between the date of this Agreement and the Closing Date will comply, in all material respects, with the Exchange Act and the Securities Act, as the case may be. As of their respective filing dates, or, if amended or superseded by a subsequent filing made prior to the date of this Agreement, as of the date of the last such amendment or superseding filing prior to the date of this Agreement, the Parent SEC Reports did not, or in the case of the Parent SEC Reports filed by Parent on or after the date hereof will not, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, except to the extent that the information in such Parent SEC Reports has been amended or superseded by a later Parent SEC Report filed prior to the date of this Agreement. Since October 1, 2006, Parent has filed with the SEC all reports required to be filed by it under the Exchange Act. No Parent Subsidiary is required to file any form, report or other document with the SEC. There are no outstanding loans or other extensions of credit made by Parent or any of the Parent Subsidiaries to any executive officer (as defined in Rule 3b-7 under the Exchange Act) or director of Parent. Parent has not, since the enactment of the Sarbanes-Oxley Act, taken any action prohibited by Section 402 of the Sarbanes-Oxley Act. No executive officer of Parent has failed in any respect to make the certifications required of him or her under Section 302 or 906 of the Sarbanes-Oxley Act with respect to any Parent SEC Report and to Parent’s knowledge the applicable executive officers anticipate making such certifications in Parent’s Annual Report on Form 10-QSB for the quarter ended June 30, 2008. Parent has made available to Company true, correct and complete copies of all material written correspondence between the SEC, on the one hand, and Parent and any of the Parent Subsidiaries, on the other hand since October 1, 2006. As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters received from the SEC staff with respect to the Parent SEC Reports. To the knowledge of Parent, none of the Parent SEC Reports is the subject of ongoing SEC review or outstanding SEC comment. None of the Parent Subsidiaries is required to file periodic reports with the SEC pursuant to the Exchange Act.

3.6 Financial Statements . As of the dates on which they were filed or amended prior to the date of this Agreement in the Parent SEC Reports filed prior to the date of this Agreement, the audited consolidated financial statements and unaudited consolidated interim financial statements of Parent included in such Parent SEC Reports (i) were prepared in accordance with generally accepted accounting principles in all material respects applied on a consistent basis throughout the periods indicated (except as may be indicated in the notes thereto and except, in the case of the unaudited interim statements, as may be permitted under Form 10-QSB of the Exchange Act) and (ii) fairly presented, in all material respects (except as may be indicated in the notes thereto and subject, in the case of any unaudited interim financial statements, to normal year-end adjustments that would not be reasonably expected to be material in amount), the consolidated financial position, results of operations and cash flows of Parent and the consolidated Parent Subsidiaries as of the respective dates thereof and for the respective periods indicated therein (subject, in the case of financial statements for any quarter of the current fiscal year, to normal year-end audit adjustments).

3.7 Absence of Undisclosed Liabilities . The Parent has no material liabilities of any nature, whether accrued, absolute, contingent or otherwise, of a nature required by generally accepted accounting principles to be reflected in a consolidated balance sheet or disclosed in the notes thereto, other than liabilities (i) adequately reflected, accrued or reserved against on the Parent Balance Sheet (as defined herein), (ii) included in Section 3.7 of the Parent Disclosure Schedule or (iii) incurred since March 31, 2008, in the ordinary course of business consistent with past practice, or (iv) which have been discharged or paid in full prior to the date of this Agreement. The consolidated, unaudited balance sheet of Parent as of March 31, 2008 is referred to herein as the “Parent Balance Sheet.”

3.8 Absence of Adverse Changes . Since September 30, 2007 through the date of this Agreement, except as contemplated by this Agreement, whether taken before or after the date of this Agreement (i) the Parent and the Parent Subsidiaries have conducted their respective businesses in all material respects in the ordinary course consistent with past practice and (ii) there has not been any change, event or circumstance that has had a Parent Material Adverse Effect.

3.9 Compliance with Laws .

(a) Parent and each of the Parent Subsidiaries have all required franchises, tariffs, grants, licenses, permits, easements, variances, exceptions, consents, certificates, clearances, accreditation, approvals, orders and authorizations of any Governmental Entity necessary for Parent and each of the Parent Subsidiaries to operate and use their properties and assets and to conduct their businesses as presently operated, used and conducted (“ Parent Permits ”) other than those the failure of which to possess would not have a Parent Material Adverse Effect. Neither Parent nor any of the Parent Subsidiaries has received written notice from any Governmental Entity or third party that any Parent Permit is subject to any adverse action, including but not limited to, suspension, termination, revocation or withdrawal, except where the failure to have any such Parent Permit or the receipt of such notice would not have or reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. The Parent Permits are in full force and effect, except for any failures to be in full force and effect that, individually or in the aggregate, would not have or reasonably be expected to have a Parent Material Adverse Effect. Parent and each of the Parent Subsidiaries is in compliance with the terms of the Parent Permits, as applicable, except for such failures to comply that, individually or in the aggregate, would not have or reasonably be expected to have a Parent Material Adverse Effect.

(b) Parent and the Parent Subsidiaries are not in violation of any federal, state, local or foreign law, ordinance or regulation or any order, judgment, injunction, decree or other requirement of any Governmental Entity, applicable to Parent or any of the Parent Subsidiaries or by which its or any of their respective properties are bound, except for violations of any of the foregoing which would not, in the aggregate, reasonably be expected to have a Parent Material Adverse Effect.

3.10 Actions and Proceedings . There are no outstanding orders, judgments, injunctions, decrees or other requirements of any Governmental Entity against Parent, any Parent Subsidiary or any of their respective assets or properties, except for those that would not, individually or in the aggregate, have a Parent Material Adverse Effect. There are no actions, suits or claims or legal, administrative or arbitration proceedings pending or, to the knowledge of Parent, threatened against Parent, any Parent Subsidiary or any of their respective securities, assets or properties, other than any such suit, claim, action, proceeding, arbitration, mediation or investigation that would not, individually or in the aggregate, have a Parent Material Adverse Effect.

3.11 Contracts and Other Agreements .

(a) Neither Parent nor any Parent Subsidiary is a party to or bound by, and neither they nor their properties are subject to, any contract or other agreement required to be disclosed in a Form 10-KSB, Form 10-QSB or Form 8-K of the SEC, which is not so disclosed. All of such contracts and other agreements and all of the contracts required to be set forth in Section 3.11 of the Parent Disclosure Schedule (“ Parent Material Contracts ”) are valid, subsisting, in full force and effect, binding upon Parent or the Parent Subsidiary party thereto, and, to the knowledge of Parent, binding upon the other parties thereto in accordance with their terms, except for such failures to be valid and binding or to be in full force and effect which would not, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect. There is no default under any Parent Material Contract by Parent or any of the Parent Subsidiaries and no event has occurred that with the lapse of time or the giving of notice or both would constitute a default thereunder by Parent or any Parent Subsidiaries, in each case except as would not, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect. Correct and complete copies of the Parent Material Contracts have been previously provided to the Company.

(b) Section 3.11(b) of the Parent Disclosure Schedule sets forth a list of the following contracts and other agreements to which Parent or any Parent Subsidiary is a party or by or to which they or their assets or properties are bound or subject:

(i) any agreement (A) relating to a joint venture, partnership or other arrangement involving a sharing of profits, losses, costs or liabilities with another person or entity, (B) providing for the payment or receipt by Parent or a Parent Subsidiary of milestone payments or royalties, or (C) that individually requires aggregate expenditures by Parent and/or any Parent Subsidiary in any one year of more than $100,000;

(ii) any indenture, trust agreement, loan agreement or note that involves or evidences outstanding indebtedness, obligations or liabilities for borrowed money in excess of $100,000;

(iii) any agreement of surety, guarantee or indemnification that involves potential obligations in excess of $100,000;

(iv) any agreement that limits or restricts Parent or any Parent Subsidiary to compete in any business or with any person or in any geographic area except for and any s

SITE SEARCH

AGREEMENTS / CONTRACTS

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates